These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21200140)

  • 21. P-TEFb Kinase Activity Is Essential for Global Transcription, Resumption of Meiosis and Embryonic Genome Activation in Pig.
    Oqani RK; Lin T; Lee JE; Choi KM; Shin HY; Jin DI
    PLoS One; 2016; 11(3):e0152254. PubMed ID: 27011207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
    Majello B; Napolitano G; Giordano A; Lania L
    Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
    Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
    J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDK9: A key player in cancer and other diseases.
    Franco LC; Morales F; Boffo S; Giordano A
    J Cell Biochem; 2018 Feb; 119(2):1273-1284. PubMed ID: 28722178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms controlling CDK9 activity.
    Marshall RM; Grana X
    Front Biosci; 2006 Sep; 11():2598-613. PubMed ID: 16720337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDK9/cyclin complexes modulate endoderm induction by direct interaction with Mix.3/mixer.
    Zhu H; Doherty JR; Kuliyev E; Mead PE
    Dev Dyn; 2009 Jun; 238(6):1346-57. PubMed ID: 19347956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.
    Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE
    J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
    Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
    Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the Cdk9/Cyclin T1 complex in T cell differentiation.
    Leucci E; De Falco G; Onnis A; Cerino G; Cocco M; Luzzi A; Crupi D; Tigli C; Bellan C; Tosi P; Leoncini L; Giordano A
    J Cell Physiol; 2007 Aug; 212(2):411-5. PubMed ID: 17352406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catalytic activity of Cdk9 is required for nuclear co-localization of the Cdk9/cyclin T1 (P-TEFb) complex.
    Napolitano G; Majello B; Lania L
    J Cell Physiol; 2003 Oct; 197(1):1-7. PubMed ID: 12942536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDK9: from basal transcription to cancer and AIDS.
    De Falco G; Giordano A
    Cancer Biol Ther; 2002; 1(4):342-7. PubMed ID: 12432243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.
    Michels AA; Fraldi A; Li Q; Adamson TE; Bonnet F; Nguyen VT; Sedore SC; Price JP; Price DH; Lania L; Bensaude O
    EMBO J; 2004 Jul; 23(13):2608-19. PubMed ID: 15201869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDK9 a potential target for drug development.
    Canduri F; Perez PC; Caceres RA; de Azevedo WF
    Med Chem; 2008 May; 4(3):210-8. PubMed ID: 18473913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K; Irwin D; Geyer M; Peterlin BM
    J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PAF complex and Prf1/Rtf1 delineate distinct Cdk9-dependent pathways regulating transcription elongation in fission yeast.
    Mbogning J; Nagy S; Pagé V; Schwer B; Shuman S; Fisher RP; Tanny JC
    PLoS Genet; 2013; 9(12):e1004029. PubMed ID: 24385927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells.
    Sung TL; Rice AP
    Retrovirology; 2006 Oct; 3():66. PubMed ID: 17014716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between fission yeast Cdk9, its cyclin partner Pch1, and mRNA capping enzyme Pct1 suggest an elongation checkpoint for mRNA quality control.
    Pei Y; Schwer B; Shuman S
    J Biol Chem; 2003 Feb; 278(9):7180-8. PubMed ID: 12475973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
    Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
    J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.